1. Home
  2. WBX vs MDXH Comparison

WBX vs MDXH Comparison

Compare WBX & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$3.12

Market Cap

65.2M

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.62

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
MDXH
Founded
2015
2003
Country
Spain
Belgium
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
65.2M
68.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
WBX
MDXH
Price
$3.12
$0.62
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$4.75
$7.67
AVG Volume (30 Days)
10.2K
238.6K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.10
$30.78
Revenue Next Year
$94.11
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.40
52 Week High
$7.83
$5.33

Technical Indicators

Market Signals
Indicator
WBX
MDXH
Relative Strength Index (RSI) 45.72 45.51
Support Level $2.77 $0.51
Resistance Level $3.19 $0.75
Average True Range (ATR) 0.18 0.04
MACD 0.01 -0.02
Stochastic Oscillator 19.87 7.49

Price Performance

Historical Comparison
WBX
MDXH

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: